MEMPHIS, Tenn.- (February 13, 2018) - Christie® Medical Holdings, the leader in near-infrared vein finding technology, will be displaying VeinViewer® at the 2018 American Academy of Dermatology Annual Meeting from February 16-20 at the San Diego Convention Center in California in booth No. 4930. Attendees will learn how they can take their practice to the next level with VeinViewer, the only high definition vein visualization technology. Conference participants are invited to in-booth demonstrations of the VeinViewer Vision2 and VeinViewer Flex to see how they can improve targeting for cosmetic procedures and potentially reduce complications.
VeinViewer uses near infrared (NIR) light to detect superficial veins by projecting the vein pattern directly onto the skin in real-time. Clinicians are easily able to identify and avoid vessels, including veins that are commonly clustered around the eyes, when performing cosmetic injections. VeinViewer can see peripheral veins up to 10mm deep and blood patterns up to 15mm deep, making VeinViewer ideal for assisting with injectable procedures. Additionally, VeinViewer has been shown to help with target mapping for vein treatment procedures, such as sclerotherapy, through identification of the deeper feeder vein for effective treatment of spider telangiectasia.
“Attendees to AAD will see how VeinViewer can improve the patient experience and comfort,” says George Pinho, president, Christie Medical Holdings. “By easily identifying vessels, VeinViewer can help circumvent potential complications and help promote better patient outcomes.”
To learn more about Christie vein finding devices: VeinViewer Vision2 and VeinViewer Flex please visit www.christiemed.com.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit www.christiemed.com.
For cautions associated to Christie Medical Holdings products, please visit www.christiemed.com/cautions.